ArticleFrontiers in molecular medicine2024

DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome.

Grace Haroun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.